North America Transfer Membrane Market Size, Share & Industry Trends Analysis Report by Product, Application, End-User, Country and Growth Forecast, 2022-2028

The North America Transfer Membrane Market should witness market growth of 3.5% CAGR during the forecast period (2022-2028).

Proteins are moved off of a gel using electroblotting or electro transfer techniques, which depend on the electrophoretic mobility of proteins. The methods include bringing a polyacrylamide gel that contains proteins into proximity to a nitrocellulose membrane, PVDF membrane, or other appropriate protein-binding support. The gel-membrane pair is then 'sandwiched'between two electrodes, normally immersed in a conducting solution, in the next step (transfer buffer). The proteins leave the gel and travel to the membrane's surface when an electric field is introduced, where they firmly attach themselves.

The protein pattern that existed in the polyacrylamide gel is replicated in the membrane that is produced. The gel is initially adjusted in the transfer buffer before conducting a wet transfer. The gel is then added to the 'transfer sandwich'of filter paper, gel, and membrane, which is held together by a support grid and cushioned pads. In a tank with a transfer buffer filled to the top, the supported gel sandwich is positioned vertically between stainless steel/platinum wire electrodes.

In 2019, the US pharmaceutical sector spent around $83 billion on R&D. These costs were incurred for various activities, including incremental improvements like product extensions, the discovery and testing of novel medications, and clinical testing for marketing or safety monitoring. When accounting for the impacts of inflation, the sum represents an increase of around ten times what the sector spent annually in the 1980s. Drug firms now spend a larger portion of their income on research and development: Pharmaceutical businesses spent about twice as much on R&D in 2019 than in 2000, or roughly one-quarter of their sales. This revenue share is higher than other knowledge-based businesses like semiconductors, technological hardware, and software.

The US market dominated the North America Transfer Membrane Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $106,046 Thousands by 2028. The Canada market is poised to grow at a CAGR of 5.8% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 4.9% during (2022-2028).

Based on Product, the market is segmented into PVDF, Nitrocellulose and Nylon. Based on Transfer Method, the market is segmented into Dry Electro Blotting (Dry Transfer), Semi-dry Electro Blotting (Semi-dry Transfer), Wet or Tank Transfer and Others. Based on Application, the market is segmented into Western Blotting, Southern Blotting, Northern Blotting and Others. Based on End-User, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, Academic & Research Institutes and Diagnostic Labs. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, PerkinElmer, Inc., Abcam Plc, Santa Cruz Biotechnology, Inc., ATTO Corporation, Azure Biosystems, Inc., and GVS S.p. A.

Scope of the Study

By Product

• PVDF
• Nitrocellulose
• Nylon

By Transfer Method

• Dry Electro Blotting (Dry Transfer)
• Semi-dry Electro Blotting (Semi-dry Transfer)
• Wet or Tank Transfer
• Others

By Application

• Western Blotting
• Southern Blotting
• Northern Blotting
• Others

By End-User

• Biopharmaceutical & Pharmaceutical Companies
• Academic & Research Institutes
• Diagnostic Labs

By Country

• US
• Canada
• Mexico
• Rest of North America

Key Market Players

List of Companies Profiled in the Report:

• Thermo Fisher Scientific, Inc.
• Danaher Corporation
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• PerkinElmer, Inc.
• Abcam Plc
• Santa Cruz Biotechnology, Inc.
• ATTO Corporation
• Azure Biosystems, Inc.
• GVS S.p. A

Unique Offerings

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free